Simple, Sensitive, and Scalable: QuantideX® Suite of Assays for Targeted MRD Monitoring of Leukemic Fusions

Simple, Sensitive, and Scalable: QuantideX® Suite of Assays for Targeted MRD Monitoring of Leukemic Fusions

For highly sensitive detection of leukemic fusions using widely available qPCR equipment, Asuragen’s QuantideX qPCR BCR-ABL* kits offer IVD or RUO testing capabilities for molecular laboratories of any size. Learn about key features of these assays and see real-world performance data.

*For Research Use Only. Not for use in Diagnostic procedures.

 

Back To
Top